{"podcast":{"title":"HCPLive Podcasts","slug":"hcplive-podcasts-19526","podcast_index_feed_id":19526,"rss_url":"https://audioboom.com/channels/5004077.rss","website_url":"https://audioboom.com/channels/5004077","image_url":"https://audioboom.com/i/40144427.png","author":"HCPLive.com","episode_count":243,"summary":"Your destination feed for medical, health care and clinical science podcasts courtesy of HCPLive—featuring our shows Medical Ethics Unpacked, New Insight, and 5 Stories in Under 5.","last_synced_at":null,"page_url":"https://stenobird.com/podcast/hcplive-podcasts-19526"},"episode":{"title":"Joint Ventures: Nipocalimab Advances and a Deucravacitinib Decision Looms","slug":"joint-ventures-nipocalimab-advances-and-a-deucravacitinib-decision-looms","published_at":"2026-05-28T19:01:00+00:00","page_url":"https://stenobird.com/podcast/hcplive-podcasts-19526/joint-ventures-nipocalimab-advances-and-a-deucravacitinib-decision-looms","show_page_url":"https://stenobird.com/podcast/hcplive-podcasts-19526","url":"https://audioboom.com/posts/8909059","audio_url":"https://audioboom.com/posts/8909059.mp3?modified=1779994664&sid=5004077&source=rss","summary":"In this episode of Joint Ventures , hosts Jack Arnold, MBBS, PhD, an academic clinical lecturer in rheumatology at the University of Leeds, and Rihards Buss, MBBS, a consultant rheumatologist at Freeman Hospital, dive into 2 emerging therapeutic strategies with the potential to reshape care for systemic lupus erythematosus (SLE) and psoriatic arthritis (PsA): Fc receptor blockade with nipocalimab and tyrosine kinase 2 (TYK2) inhibition with deucravacitinib, distinct pathways united by a shared goal of greater precision in immune modulation.","meta_description":"In this episode of Joint Ventures , hosts Jack Arnold, MBBS, PhD, an academic clinical lecturer in rheumatology at the University of Leeds, and Rihards Bu…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1500,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hcplive-podcasts-19526/episodes/joint-ventures-nipocalimab-advances-and-a-deucravacitinib-decision-looms/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hcplive-podcasts-19526/joint-ventures-nipocalimab-advances-and-a-deucravacitinib-decision-looms.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}